Literature DB >> 16265670

Oligodendrocyte precursor cells generate pituicytes in vivo during neurohypophysis development.

Isabelle Virard1, Delphine Coquillat, Mircea Bancila, Sovann Kaing, Pascale Durbec.   

Abstract

In the vertebrate brain, much remains to be understood concerning the origin of glial cell diversity and the potential lineage relationships between the various types of glia. Besides astrocytes and myelin-forming oligodendrocytes, other macroglial cell populations are found in discrete areas of the central nervous system (CNS). They share functional features with astrocytes and oligodendrocytes but also display specific characteristics. Such specialized cells, called pituicytes, are located in the neurohypophysis (NH). Our work focuses on the lineage of the pituicytes during rodent development. First, we show that cells identified with a combination of oligodendrocyte precursor cell (OPC) markers are present in the developing rat NH. In culture, neonatal NH progenitors also share major functional characteristics with OPCs, being both migratory and bipotential, i.e. able to give rise to type 2 astrocytes and oligodendrocytes. We then observe that, either in vitro or after transplantation into myelin-deficient Shiverer brain, pieces of NH generate myelinating oligodendrocytes, confirming the oligodendrogenic potentiality of NH cells. However, no mature oligodendrocyte can be found in the NH. This led us to hypothesize that the OPCs present in the developing NH might be generating other glial cells, especially the pituicytes. Consistent with this hypothesis, the OPCs appear during NH development before pituicytes differentiate. Finally, we establish a lineage relationship between olig1+ cells, most likely OPCs, and the pituicytes by fate-mapping experiments using genetically engineered mice. This constitutes the first demonstration that OPCs generate glial cells other than oligodendrocytes in vivo. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16265670     DOI: 10.1002/glia.20282

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  7 in total

1.  Serine/threonine-protein kinase PFTK1 modulates oligodendrocyte differentiation via PI3K/AKT pathway.

Authors:  Hai Jie Yang; Lei Wang; Mian Wang; Shuang Ping Ma; Bin Feng Cheng; Zhi Chao Li; Zhi Wei Feng
Journal:  J Mol Neurosci       Date:  2014-10-30       Impact factor: 3.444

2.  Isolation of tumour stem-like cells from benign tumours.

Authors:  Q Xu; X Yuan; P Tunici; G Liu; X Fan; M Xu; J Hu; J Y Hwang; D L Farkas; K L Black; J S Yu
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

Review 3.  Advances in Understanding of Structural Reorganization in the Hypothalamic Neurosecretory System.

Authors:  Seiji Miyata
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-17       Impact factor: 5.555

4.  Leukemia inhibitory factor inhibits erythropoietin-induced myelin gene expression in oligodendrocytes.

Authors:  Georgina Gyetvai; Cieron Roe; Lamia Heikal; Pietro Ghezzi; Manuela Mengozzi
Journal:  Mol Med       Date:  2018-09-27       Impact factor: 6.354

5.  Single-Cell Molecular and Cellular Architecture of the Mouse Neurohypophysis.

Authors:  Qiyu Chen; Dena Leshkowitz; Janna Blechman; Gil Levkowitz
Journal:  eNeuro       Date:  2020-01-17

6.  CRHR1 mediates the transcriptional expression of pituitary hormones and their receptors under hypoxia.

Authors:  Tong Ying Wang; Fang Yuan Xia; Jing Wen Gong; Xiao Kang Xu; Min Chao Lv; Mahanand Chatoo; Bilal Haider Shamsi; Meng Chen Zhang; Qian Ru Liu; Tian Xing Liu; Dan Dan Zhang; Xin Jiang Lu; Yang Zhao; Ji Zeng Du; Xue Qun Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-02       Impact factor: 6.055

7.  Mature oligodendrocytes bordering lesions limit demyelination and favor myelin repair via heparan sulfate production.

Authors:  Magali Macchi; Karine Magalon; Céline Zimmer; Elitsa Peeva; Bilal El Waly; Béatrice Brousse; Sarah Jaekel; Kay Grobe; Friedemann Kiefer; Anna Williams; Myriam Cayre; Pascale Durbec
Journal:  Elife       Date:  2020-06-09       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.